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Corruption and Anti-corruption Actions in Healthcare
Abstract: Bribery is a  common phenomenon. It has various social, moral, economic and 
political implications, it challenges good management, hinders development and disrupts 
competition. It violates justice, challenges human rights and impedes the fight against po-
verty. It also increases the cost of running business, introduces uncertainty in commercial 
transactions, increases the cost of goods and services as well as deteriorates their quality, 
which may lead to the loss of life and property, the loss of trust in institutions, and a disrup-
tion of honesty and effective functioning of the markets [ISO 37001].
The objective of the article is to present various kinds of corruption that occur in the he-
althcare sector as well as different anti-corruption actions taken by the entities. The artic-
le is based on current  subject literature, an analysis of legal acts and various reports publi-
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shed by institutions fighting against corruption in the healthcare. The article is a desk rese-
arch analysis.
Key words: bribery, kinds of corruption, healthcare, anti-corruption actions
Introduction
Corruption is a common phenomenon and occurs, to a different extent, in all countries. 
Its intensity in a given country depends above all on the social consent towards corrup-
tive incidents [Kowalczyk 2012, p. 14]. We have to be aware of the fact that corruption in 
healthcare entails also substantial financial losses. Firstly, we have to decide if we want 
to pay for something for which we had already paid by way of social insurance contri-
butions, and secondly, if we, as a society, want to finance independent services, benefits 
and pensions through a “bribery” [Ministerstwo Zdrowia 2006, p. 3].
Types of corruption
We should mention here what stipulated the sentence issued by the Court of Appeals in 
Lublin on 13th October 2009 (II Aka 118/09): there are no factual justifications to promo-
te an idea that the custom of rewarding doctors for saving life or health is commonly ac-
cepted and treated as a social norm, bearing in mind that a doctor is rewarded for their 
job within the framework of public healthcare system, given they work in entities finan-
ced from the public funds [Łokaj 2016].
An offence commonly known as corruption in penal law is known as bribery. Penal 
law distinguishes two types of bribery: passive and active.
Passive bribery (also known as venality) is defined in Article 228 of Penal Code as an 
act committed by a person who in connection with the public office in which they serve 
accepts financial or personal gain or the promise thereof. 
Active bribery is defined in Article 229 of Penal Code as an act committed by a per-
son who gives or promises to give financial or personal gain to a person serving in a pu-
blic office in connection with the office thereof. 
The sanctions pending for the commitment of the aforementioned offences, both 
active and passive bribery, depend on the type of the offence and may vary (fine, impri-
sonment for a term of up to 12 years) [Ministerstwo Zdrowia 2006, p. 4].
According to the Polish Penal Code, there are two premises that allow to conclude 
that an offence of passive bribery has been committed. First, the subject of the offence 
can only be a person serving in a public office. Second, this person has to accept finan-
cial or personal gain or a promise thereof. Only if both aforementioned premises are ful-
filled can we talk about an offence under Article 228 of Penal Code.
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According to the jurisprudence of the Supreme Court, it should be assumed that me-
dical professionals employed in healthcare units (public and private) who provide health 
services financed from the public funds are also public officers, as stipulated in Article 
228 of Penal Code. The Supreme Court explicitly stated that the decisive factor to conc-
lude that proving health services lies within the scope of the definition of a public officer 
is not the type of healthcare unit there are provided in (public or private), but whether 
they are provided to the entitled person (patient) within health services financed from 
the public funds. A medical professional also serves in a public office, performing not 
only medical, but also administrative tasks [Karkowska, Karkowski 2017, p. 133].
It should be emphasised that the legislator even further tightens the punishability in 
the case of committing passive bribery by accepting financial gains of substantial value, 
an act punishable by imprisonment of between 2 and 12 years (Article 228 paragragh 5 
of Penal Code). We have to agree with the principle expressed in the law according to 
which, in a case when the gift is of small value, we should contemplate the possibility 
of dealing with an act of less importance, regulated in Article 228 paragraph 2 of Penal 
Code. Such a case would be, in particular, delivering gain that exceeds socially accepted, 
i.e. customary rewards only to a limited extend, and is a small gift (flowers, sweets, a bot-
tle of cognac etc.) given as a token of gratitude for kindness or particular efforts made in 
connection with the functions fulfilled. It could be interpreted that giving doctors small 
gifts such as flowers, sweets or coffee is permissible. However, such a gift can only be gi-
ven after the treatment and should not be expected by the doctor. It is supposed to be 
a token of sincere gratitude of the patient for the treatment received. At the same time 
it should be stressed that each case of such a situation should be analysed individually. 
Current praxis in the European Union shows that any gifts for the doctors are prohibited, 
and Polish authorities clearly go in the same direction [Łokaj 2016].
While contemplating corruption as a phenomenon that should not happen in good 
management, a wide definition proposed by the World Bank is used: it is any abuse of 
a  public office aiming at obtaining personal benefits. This benefit may be of various 
kinds: financial or material benefit, increase in power or informal influence, demonstra-
tion of the possibility, unavailable to other people, to solve a difficult problem. The most 
common type of corruption is bribery, given and received in situations when there sho-
uld be no financial exchange between the parties. A patient giving a bribe may have dif-
ferent motives which to a great extend depend on the circumstances and the type of ob-
stacles which by way of an informal pay are going to be solved, as is the intention of the 
giver. It can be getting access to a service – consultation, examination, hospitalisation or 
medicine – shortening the waiting time if it is considered to be too long, improving the 
quality of the health service or the conditions in which it is performed. 
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Other type of corruption is theft. Petty theft (dressings, small equipment) happen 
almost everywhere, and even though they bring in losses, they are normally tolerated. 
A more complex care is using rooms and equipment belonging to a public entity to re-
ceive private patients. It happens both in systems in which various forms of coexisten-
ce of two sectors are legalised, and in the countries where the rules of coexistence are 
not settled. As a theft of time – although this term is rarely used – we should understand 
dedicating labour time remunerated by a public institution to other activities, including 
additional job.
Moreover, there may be an agreement between a doctor and a patient as to the issu-
ing of a sick leave or health assessment form, used to gain an independent service. So-
metimes doctors collude to issue the expected opinion about the necessity to perform 
an operation from which a doctor derives extraordinary gains. Certificates and opinions 
may be used in tenders with the insurer or payer. Also, drugs which use is not sufficiently 
justified are frequently prescribed [Włodarczyk 2014].
Corruption and pharmaceutical companies
As far as pharmaceutical market is concerned, in the case when a given drug is being 
considered to be placed on the list of reimbursed drugs, the subjects striving to a posi-
tive decision may address corruptive offers to the decision-makers and opinion-issuers. 
Unfortunately, corruptive methods may also be used to present untrue or inexact infor-
mation. Where drugs are concerned, these may be investigation results of clinical effec-
tiveness, application conditions, as well as patients safety. Pharmaceutical companies fi-
nance patients’ organizations, convincing them about the positive aspects of their drugs 
and expecting that the pressure exerted by persons seemingly unconnected to the ma-
nufacturers will be strong enough as to influence the decisions of the administrative bo-
dies and the cash flow. Sometimes pharmaceutical companies openly admit that one of 
the aims of the functioning of patients groups is promoting the increase of refunding po-
licy of innovative drugs, which normally meets with the objection or resistance of sub-
jects responsible for managing public funds. The representatives of patients groups and 
organizations are rarely inclined to reveal their connections with pharmaceutical compa-
nies. Different forms of camouflage are frequently used, thanks to which money transfers 
for positive, pro-social activities make impression [Włodarczyk 2014].
Another restriction existing in the pharmaceutical market is a prohibition set under 
Article 58 of Act on Pharmaceutical Law (unified text Dz.U. [Journal of Laws] from 2016, 
item 2142, with subsequent amendments) by which it is prohibited to direct advertise-
ments of medical products to persons authorised to issue prescriptions and persons tra-
ding in drugs by way of giving, offering and promising them material gains, gifts and va-
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rious forms of help, rewards, trips, as well as organising and financing conferences adver-
tising  medical products, during which the extend of hospitality exceeds the main objec-
tive of the conference. However, it does not include items of a value not exceeding 100 
PLN, connected with the medical or pharmaceutical practice, labelled with the compa-
ny’s or medical product’s trademark. The aim of this norm is to prohibit exercising pres-
sure on doctors and a certain form of hidden bribery used to gain preference for speci-
fic medical products. 
Nevertheless, the evaluation of the doctor’s behaviour may be difficult from the legal 
point of view, as the doctor uses the gift in front of the patients, becoming in this way an 
intermediary of an advertising message. It is worth pointing out that this message is di-
rected to the public. It all happens so naturally that by hanging in the consulting room 
a calendar with a logo of medical products or writing down the dosage of medications 
on a sheet of paper with the name of another medication the doctor may not be aware 
of participating in an advertising process [Stankiewicz 2016].
Passive bribery
Corruption includes such offences as venality, bribery and paid protection. In public 
procurements passive bribery consists in accepting (or demanding), in connection with 
a public procurement in progress, material or personal gain (or a promise thereof ) by 
a  person having public funds at their disposal. The offence of venality (Article 228 of 
Penal Code) is an individual offence, that means only a person indicated in the provision 
can commit it, i.e. public officer [Soszyńska-Purtak 2016]. 
Group for Counteracting Frauds and Corruption in 
Healthcare
In 2006 the Minister of Health created the Group for Counteracting Frauds and Corrup-
tion in Healthcare as a consultative-advisory body, the tasks of which include in particu-
lar [Zarządzenie 2006]:
 · Identification of the areas and forms of frauds and corruption in healthcare;
 · Presenting additional proposals of anticorruption activities and counteracting frauds 
in healthcare within an anticorruption strategy;
 · Presenting proposals of activities within an outreach campaign about the fight aga-
inst corruption in healthcare;
 · Presenting proposals of actions within international cooperation programmes con-
cerning counteracting frauds and corruption in healthcare.
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The aforementioned functions are complemented by a consultative-advisory func-
tion connected with the realisation of tasks imposed on Minister of Health by the Go-
vernmental Anticorruption Programme for the years 2014–2019.
Moreover, in November 2006 the Ministry of Health prepared a guidebook addres-
sed to the patients: “Korupcja nie wyjdzie nam na zdrowie…” (Corruption won’t heal us), 
the objective of which was to explain what corruption in healthcare is and what kinds of 
legal protection a patient has in a situation when the occurrence of corruptive actions 
is suspected. The guidebook included sample situations describing the phenomenon of 
corruption, as well as defined what should be done and who to go to in order to counte-
ract corruption effectively. The objective of the guidebook was also making the readers 
aware that corruption is an offence prosecuted ex officio [Korupcja… 2006].
Report of the European Commission
At the end of 2013 the European Commission published a report about corruption in he-
althcare in the UE member states. A particular emphasis was put on three areas of heal-
thcare: providing health services (various forms of informal payments), ordering and cer-
tifying medical products, and ordering and granting marketing authorization for a medi-
cinal product [European Commission 2013, p. 12].
According to the authors, corruption is mostly evident in the relations between do-
ctor and patient. In the area of medical equipment and drugs, corruption occurs most 
commonly in public procurements and inadequate marketing relations. In healthcare 
sector, corruption happens in every UE member states, however, it differs in terms of 
the characteristics and the incidence of its various forms. Corruption in public procure-
ments, occurring in all Europe, takes form of inadequate marketing relations, which con-
sist in transferring money, financing conferences, trips or other incentives. Corruption in 
public procurements seems to happen rarely in those countries in which public procure-
ments sectors are strictly regulated.
Corruption in healthcare may be favoured by certain weaknesses in the system, such 
as low wages, too limited funds for healthcare, connections with other companies; or lo-
ops in the supervision system, anticorruption legislation or the effectiveness of the co-
urt system. One of the factors considered to favour corruption is common consent for it, 
or al least a certain grade of tolerance. The authors of the report notice, however, that in 
almost all member states the social consent for corruption has decreased. It has to po-
inted out that there is no single effective anticorruption strategy. According to the inve-
stigation, such policy has to be based on strong, independent institutions and the lack 
of social consent for it. 
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Investigation results show that the main area of corruption in Polish healthcare are 
public procurements. The authors point out that Poland does not use a unified system 
of procurements for this sector.  
Another important problem indicated by the EC report is nepotism. According to 
the authors, it is particularly evident in university college hospitals. In Poland, especially 
among doctors, prevails a belief that medicine is a family business, passed on from pa-
rents to children. A characteristic feature of the Polish healthcare is also a lack of sensiti-
vity for a potential conflict of interests. 
The main factor favouring corruption – even though its scale is smaller than a couple 
of years ago – is the mentality of the Polish society, evident in, for example, social accep-
tance for giving bribes and not seeing negative effects of corruption.
According to the respondents, the problem of informal payments in Polish healthca-
re has significantly decreased recently, what is connected to the access to private health-
care services.  Nevertheless, the problem continues. 
Central Anticorruption Bureau
According to the “Expected corruption threats in Poland” report prepared in 2013 by 
Central Anticorruption Bureau (CBA), one of the areas exposed to corruption is health 
protection.  The threats observed in this area are [Przewidywane… 2013]:
 · Assigning public funds by the provincial departments of National Health Fund (NFZ) 
to the purchase orders of medical services, drug reimbursement, orthopaedic applian-
ces and aid materials, 
 · Carrying out public procurements for the purchase and delivery of equipment and 
medical appliances, and subcontracting external subjects for medical services,  
 · Drug legislation process, i.e. illegal influence on legislative processes, also in terms 
of obtaining certain medical indications for drug use, the size of package available for 
sale, placing the drug on the list of reimbursed drugs,
 · Sponsoring doctors and labour organizations of medical professionals by pharma-
ceutical companies. 
Moreover, limited access to or the lack of selected drugs in the market may trigger 
the necessity to initiate emergency import procedure of bearer prescription medici-
nal products, which will generate additional costs for the state budget, independent 
from the planned reimbursement costs. Corruption and mismanagement may also oc-
cur in the interaction between doctors, pharmacists and retailers. It consists in buying 
out drugs from the pharmacies – using false or ungrounded prescriptions – and then ta-
king them out of the country, which entails unjustified reimbursement costs, and there-
fore losses for the state budget. 
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Also, conflicts of interests between healthcare units, voivodship offices and provin-
cial departments of NFZ increase the probability of corruption-related irregularities. The 
interested parties may, for example, influence the decisions of NFZ concerning the amo-
unt of contracts assigned to them. The problem could also lie in the ineffective supervi-
sion over the financial situation of the hospitals, which in extreme cases could lead to un-
controlled privatisation processes. Threats for the economic interest of the state and cor-
ruption threats may also occur in the area of transplantology. Lack of legal instruments 
allowing for effective supervision may favour the development of illegal transplanta-
tion of tissues and organs. Potential threats may derive form the fact that private banks 
of tissues and organs and transplantation clinics (which often use illegally obtained ma-
terials) may lead public entities to bankruptcy by giving orders to foreign subjects [Prze-
widywane… 2013].
Implementation of the Governmental Anticorruption 
Programme for 2014–2019
The Governmental Anticorruption Programme for 2014-2019 is the main instrument for 
the coordination of national anticorruption policy. Counteracting and preventing cor-
ruption requires a systemic attitude, encompassing  synchronised objectives and actions 
of all subjects involved in the fight. The aim of the Governmental Programme is to limit 
corruption by increasing prevention and education, both in society and in public admi-
nistration, and by a more effective fight against corruption offences. Corruption preven-
tion and education was intensified, as forming an awareness of the harmful effects of 
corruption is an indispensable condition for limiting the occurrence of this pathology 
[Uchwała Nr 37… 2014]. The Governmental Programme contemplates tasks and activi-
ties in those fields of social life that are mostly threatened by corruption, for example he-
althcare. The tasks include increasing prevention of corruption in the healthcare system, 
whereas the activities include the diagnosis of needs and activities, also in terms of legal 
norms, carried out to prevent corruption in the healthcare system, in particular in terms 
of [Najwyższa Izba Kontroli 2016]:
 · assigning public funds by the provincial departments of National Health Fund (NFZ) 
to the purchase orders of medical services, drug reimbursement, orthopaedic applian-
ces and aid materials, 
 · carrying out public procurements for the purchase and delivery of equipment and 
medical appliances, and subcontracting external subjects for medical services,
 · registering drugs, 
 · interactions patient-medical personnel, doctor/medical professional organisations – 
pharmaceutical companies, and recommendations. 
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Conclusion
Having analysed the above-mentioned legal acts and documents, it turns out that even 
though there are sanctions for corruption, this phenomenon continues, in particular in 
the healthcare sector. The remedy for this could be the lack of social consent towards 
such actions and the introduction of systems for the management of anti-corruption ac-
tions at the micro level, i.e. an organisation, an issue that has been described in the artic-
le “PN-ISO 37001 management systems for anti-corruption actions and anti-corruption 
procedure in Jan Paweł II Hospital in Bełchatów.
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Legal acts:
Uchwała Nr 37 Rady Ministrów z dnia 1 kwietnia 2014 r. w sprawie Rządowego Programu Przeciw-
działania Korupcji na lata 2014-2019 (M.P. z 2014 r. poz. 299)
Ustawa – prawo farmaceutyczne (tekst jedn.: Dz.U. z 2016 r. poz. 2142, z późn. zm.)
Ustawa z dnia 6 czerwca 1997 r. Kodeks karny (tekst jedn. Dz.U. z 2016 poz. 1137, ze zm.)
Zarządzenie Ministra Zdrowia z dnia 4 października 2006 r. w sprawie powołania Zespołu do 
spraw przeciwdziałania oszustwom i korupcji w ochronie zdrowia (Dz.Urz. MZ z 2006 r. nr 15, 
poz. 74 z późn. zm.)
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